Drugs Made In America Acquisition Corp. Units
- DMAAU
- NASDAQ
- Shell Companies
- SPAC Units
- Blank Check Company
$11.29
Today −0.04%Quote Oct 19, 2026, 03:13 PM UTC
Limited analysis: bank-specific metrics are not in this version yet. Debt, free-cash-flow and generic valuation ratios are hidden for this company.
+4.73%over the last month
Max drawdown 0.0%From 1-month high 0.0%3 months +5.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Drugs Made In America Acquisition Corp. Units
Drugs Made In America Acquisition Corp. operates as a special purpose acquisition company (SPAC). Its primary objective is to achieve a business combination, which may involve a merger, an asset acquisition, a share exchange, or a corporate restructuring, with one or more existing enterprises.
Sector
Financial services
Industry
Shell Companies
Exchange
NASDAQ
Employees
2
Market value
$263.8M
Quote Oct 19
Floor
$10.99
2.7% below price
Resistance
$11.26
Price is above this level
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about DMAAUPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free